J. Sun et al. / Tetrahedron Letters 52 (2011) 5693–5696
5695
Table 2
Reactions of ketone 1 with various arylaminesa
6
7
O
5
8
R
HN
O
Entry
Arylamine
Yieldb (%)
O
Ph
1
2
3
4
5
6
7
8
9
4-MeO-PhNH2
Aniline
p-Toluidine
3 (R = 8-MeO)
4 (R = H)
5 (R = 8-Me)
6 (R = 8-Et)
7 (R = 8-EtO)
8 (R = 6-MeO)
9 (R = 7-Me)
10 (R = 8-Morc)
11 (R = 7,8-di-MeO)
12 (R = 8-Br)
—
58
54
69
71
63
55
63
65
72
52
4-Et-PhNH2
4-EtO-PhNH2
2-MeO-PhNH2
m-Toluidine
4-Mor-PhNH2
3,4-Di-MeO-PhNH2
4-Br-PhNH2
N-Me-PhNH2
10
11
d
—
a
b
c
The reaction was conducted on 1.0 mmol scale of arylamine using the optimized conditions.
Isolated yield.
Mor = morpholin-4-yl.
No reaction.
d
O
OCH3
O
5
Ph
Ph
O
O
2
1
O
O
4
Ph
Ph
OH
O
O
O
3
OCH3
O
OCH3
O
O
I
II
NH2-Ar
O
O
O
OCH3
O
O
O
-CH3OH
-OH
O
H
O
HN Ar
N
O
Ar
OCH3
Ph
O
1
Ph
O
3-12
III
Figure 3. Possible base-initiated mechanism.
4. Ding, C.; Tu, S.; Li, F.; Wang, Y.; Yao, Q.; Hu, W.; Xie, H.; Meng, L.; Zhang, A. J.
Org. Chem. 2009, 74, 6111–6119.
5. Bargellini, G. Gazz. Chim. Ital. 1906, 36, 329–332.
6. Butcher, K. J.; Hurst, J. Tetrahedron Lett. 2009, 50, 2497–2500.
7. Cvetovich, R. J.; Chung, J. Y. L.; Kress, M. H.; Amato, J. S.; Matty, L.; Weingarten,
M. D.; Tsay, F.-R.; Li, Z.; Zhou, G. J. Org. Chem. 2005, 70, 8560–8563.
8. Rychnovsky, S. D.; Beauchamp, T.; Vaidyanathan, R.; Kwan, T. J. Org. Chem.
1998, 63, 6363–6374.
enolate-like II. Subsequent Michael addition of arylamine gener-
ated species III that then underwent elimination of MeOH and
OHꢁ under basic condition to yield products 3–12. Theoretically,
this reaction also likely went through by a Lewis acid, however,
replacing NaOH with Lewis acids such as BF3, TiCl4, or FeCl3 did
not promote this reaction at all (Table 1, entries 12–14).11
In summary, reaction of methyl 4,6-O-benzylidene-3(2)-deoxy-
hexopyranosid-2(3)-ulose (1) with various arylamines under
Bargellini reaction conditions was investigated. A series of unique
enaminoketones 3–12 was obtained in 52–72% yield, and a base-
promoted mechanism was proposed.
9. Peseke, K.; Feist, H.; Cuny, E. Carbohydr. Res. 1992, 230, 319–325.
10. General experimental procedure: To a solution of methyl 4,6-O–benzylidene-
2-deoxy-a-D-erythro-hexopyran-osid-3-ulose (129 mg, 0.49 mmol) and
arylamines (0.16 mmol) in THF (10 mL) NaOH (20 mg, 0.48 mmol) were
added. The mixture was stirred at 0 °C for 0.5 h and then at room
temperature for 12 h. The solution was extracted with EtOAc, washed with
water, brine, dried over anhydrous Na2SO4 and filtered. The solvent was
removed under reduced pressure to give a residue which was then purified by
chromatography on silica gel to afford products 3–12 as yellow solid.
Acknowledgments
For (Z)-3-(4-methoxyphenylamino)-1-(2-phenyl- 4H-1,3-dioxin-6-yl) prop-2-en-
1-one (3): 1H NMR (400 MHz, CDCl3) d 12.13 (d, J = 12.4 Hz, 1H, NH), 7.59 (m,
2H, Ar), 7.41 (m, 3H, Ar), 7.40 (m, 1H, H-30), 7.02 (d, J = 9.2 Hz, 2H, ArOMe), 6.88
(d, J = 9.2 Hz, 2H, ArOMe), 6.12 (d, J = 1.6 Hz, 1H, H-20), 5.84 (d, J = 7.6 Hz, 1H,
H-2), 5.83 (s, 1H, H-50), 4.70 (dd, J = 17.2, 2.4 Hz, 1H), 4.57 (dd, J = 17.2, 3.6 Hz,
1H), 3.79 (s, 3H); 13C NMR (75 MHz, CDCl3) d 183.8, 156.6, 151.0, 146.8, 136.9,
133.4, 129.3, 128.4 (2C), 126.4 (2C), 118.1 (2C), 114.9 (2C), 105.5, 98.3, 91.50,
65.1, 55.6; MS (EI-LR) 337 (M+); HRMS (EI) calcd for C20H19NO4 (M+) 337.1314;
found 337.1295. For (Z)-1-(2-phenyl-4H-1,3-dioxin-6-yl)-3-(phenylamino) prop-
2-en-1-one (4): 54%; yellow solid; 1H NMR (300 MHz, CDCl3) d 12.04 (d,
J = 11.7 Hz, 1H), 7.58 (dd, J = 6.6, 2.7 Hz, 2H), 7.44 (m, 4H), 7.33 (t, J = 7.8 Hz,
2H), 7.08 (t, J = 7.8 Hz, 3H), 6.13 (m, 1H), 5.88 (d, J = 7.8 Hz, 1H), 5.82 (s, 1H),
4.69 (dd, J = 17.5, 2.1 Hz, 1H), 4.56 (dd, J = 17.4, 3.6 Hz, 1H); 13C NMR (75 MHz,
The authors are grateful to the Chinese National Science Foun-
dation (81072528), Shanghai Commission of Science and Technol-
ogy (10410702600, 10JC1417100, 10dz1910104), National Science
& Technology Major Project on ‘Key New Drug Creation and Man-
ufacturing Program’ (2009ZX09301-001, 2009ZX09103-062).
Supplementary data
Supplementary data associated with this Letter can be found, in
CDCl3)
d 184.3, 150.9, 145.9, 139.8, 136.9, 129.7(2C), 129.3, 128.4(2C),
126.4(2C), 124.0, 116.4(2C), 105.8, 98.3, 92.3, 65.0; MS (EI-LR) 307 (M+);
HRMS (EI) calcd for C19H17NO3 (M+) 307.1208; found 307.1190. For (Z)-1-(2-
phenyl-4H-1,3-dioxin-6 yl)-3-(p-tolyl amino)prop-2-en-1-one (5): 69%; yellow
solid; 1H NMR (300 MHz, CDCl3) d 12.06 (d, J = 12.9 Hz, 1H), 7.58 (dd, J = 7.5,
2.1 Hz, 2H), 7.45 (m, 4H), 7.13 (d, J = 8.4 Hz, 2H), 6.97 (d, J = 8.4 Hz, 2H), 6.12
(dd, J = 3.6, 2.4 Hz, 1H), 5.87 (d, J = 7.8 Hz, 1H), 5.82 (s, 1H), 4.69 (dd, J = 17.4,
2.2 Hz, 1H), 4.56 (dd, J = 17.4, 3.6 Hz, 1H), 2.32 (s, 3H); 13C NMR (75 MHz,
References and notes
1. Haak, E. Eur. J. Org. Chem. 2007, 2815–2824.
2. Haak, E. Synlett 2006, 1847–1848.
3. Li, F.; Ding, C.; Wang, M.; Yao, Q.; Zhang, A. J. Org. Chem. 2011, 76, 2820–2827.